tm logo

Trademark Search

Owners

Ocular Science, Inc.

PREDNISOLONE PO4 / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.07% OMNI BY OCULAR SCIENCE

PREDNISOLONE PO4 / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.07% OMNI BY OCULAR SCIENCE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 08 Apr 2019

Last Applicant/ Owned by

1334 Park View Ave., Suite 100

Los Angeles

CA

90266

Serial Number

87825678 filed on 08th Mar 2018

Registration Number

N/A

Correspondent Address

ERIC KELLY

5535 WESTLAWN AVE NO 180

LOS ANGELES, CA 90066

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PREDNISOLONE PO4 / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.07%" AND "BY OCULAR SCIENCE"

PREDNISOLONE PO4 / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.07% OMNI BY OCULAR SCIENCE

"PREDNISOLONE PO4 / BROMFENAC SODIUM SESQUIHYDRATE OPHTHALMIC SOLUTION 1% / 0.07%" AND "BY OCULAR SCIENCE" The mark consists of the words "Prednisolone PO4 / Bromfenac Sodium Sesquihydrate Ophthalmic Solution 1% / 0.07%" above the words of "OMNI by OCULAR SCIENCE". The "Prednisolone PO4 / Bromfenac Sodium" words are above the "Sesquihydrate Ophthalmic Solution" words. The "Sesquihydrate OphthalmiRead More

Classification Information


Class [005]
Pharmaceutical Products


Ophthalmic preparations

Mark Details


Serial Number

No 87825678

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the words "Prednisolone PO4 / Bromfenac Sodium Sesquihydrate Ophthalmic Solution 1% / 0.07%" above the words of "OMNI by OCULAR SCIENCE". The "Prednisolone PO4 / Bromfenac Sodium" words are above the "Sesquihydrate Ophthalmic Solution" words. The "Sesquihydrate Ophthalmic Solution" words are above the "1% / 0.07%" words. The "Prednisolone PO4 / Bromfenac Sodium Sesquihydrate Ophthalmic Solution 1% / 0.07%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".

Legal History


Show more

Status DateAction Taken
08th Apr 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
08th Apr 2019ABANDONMENT - NO USE STATEMENT FILED
04th Sep 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10th Jul 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Jul 2018PUBLISHED FOR OPPOSITION
20th Jun 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Jun 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
31st May 2018ASSIGNED TO LIE
16th May 2018APPROVED FOR PUB - PRINCIPAL REGISTER
16th May 2018EXAMINER'S AMENDMENT ENTERED